naltrexone hydrochloride; oxycodone hydrochloride · Pfizer · NDA 207621
Troxyca Er
Earliest generic entry, as listed · earliest of 6 marketed strengths
12 Dec 2027
No marketed reference-listed strength; date taken from all listed strengths.
Blocked by patent: US 7815934.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 7815934 | drug product · sets the listed date | 12 Dec 2027 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 6
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 207621 · 001 · discontinued | capsule, extended release, oral | 1.2MG;10MG | 12 Dec 2027 |
| 207621 · 002 · discontinued | capsule, extended release, oral | 2.4MG;20MG | 12 Dec 2027 |
| 207621 · 003 · discontinued | capsule, extended release, oral | 3.6MG;30MG | 12 Dec 2027 |
| 207621 · 004 · discontinued | capsule, extended release, oral | 4.8MG;40MG | 12 Dec 2027 |
| 207621 · 005 · discontinued | capsule, extended release, oral | 7.2MG;60MG | 12 Dec 2027 |
| 207621 · 006 · discontinued | capsule, extended release, oral | 9.6MG;80MG | 12 Dec 2027 |